Weight-loss with exercise and diet in adults with type 2 diabetes and CKD
Official title: Inflammatory Cytokines and Oxidative Stress Biomarkers Response to Life Style Modification in Diabetic Chronic Kidney Disease Patients
Run by Badr University · NCT07657286 · Data updated 2026-11-12
This study tests whether a 12-week supervised aerobic exercise program plus a calorie‑restricted diet can change inflammatory and oxidative stress biomarkers in overweight adults with type 2 diabetes and moderate chronic kidney disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 36 Years to 58 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Badr University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | June 7, 2026 |
| Main results expected | September 7, 2026 |
| Study ends | September 7, 2026 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07657286 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are sedentary adults aged 36–58 with type 2 diabetes and stage 3–4 CKD, BMI 30–35 kg/m², not on tobacco or anti-inflammatory meds, and able to participate in a supervised exercise program.
✕Probably not a fit
Patients who do not respond to lifestyle changes, have uncontrolled cardiovascular risk, or cannot safely participate in exercise may not experience biomarker improvements.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls 60 sedentary adults aged 36–58 with stage 3–4 CKD and type 2 diabetes, BMI 30–35 kg/m². Participants are randomized to receive a 12-week program of supervised aerobic treadmill training plus a 1200 kcal/day diet or standard nephrology care without lifestyle changes. Biomarkers such as TNF-α, IL-6, sCRP, CD, MDA, GSH, GPx, and SOD are measured at baseline and after 12 weeks to assess the biological impact of the lifestyle intervention. The trial aims to determine if lifestyle modification can modulate inflammatory and oxidative stress pathways in this high-risk population.
Why it matters
Potential benefit: If successful, participants may experience beneficial changes in inflammation and oxidative stress markers, which could be associated with better health outcomes.
How similar studies have gone: Previous studies in related populations have shown biomarker changes with lifestyle interventions, but this specific combination in diabetes with CKD and higher BMI is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * sedentary lifestyle for at least three months prior to enrollment * body mass index (BMI) of 30-35 kg/m². Exclusion Criteria: * using tobacco * heart failure * coronary arteries * severe heart valve problems * pregnant * liver inflammation * kidney transplant * physical injuries restricting them from exercising * utilization of anti-inflammatory medications
Where it's running
-
Mona Mohamed Abdelkhalek
Cairo, Egypt Recruiting
Study contacts
- Principal investigator: Mona Mohamed Abdelkhalek — Badr University
- Study coordinator: Mona Mohamed Abdelkhalek, assistance professor
- Email: 3m.sons@gmail.com
- Phone: 00201024056108
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CKD Awareness, Referrals, Education, and Support for Early-Stage CKD in Adults with Diabetes
This intervention tests whether education, motivational support, and social backing delivered virtually can help adults with diabetes and early CKD slow kidney decline and stay engaged with care.
-
Examining how metabolism relates to body composition and size
This study is testing how metabolism connects to body size and composition in both healthy people and those with metabolic disorders to see if more accurate measurements can improve our understanding.
-
Health checks for diabetes, blood pressure, and kidney health in Indigenous communities.
This study is testing health checks for diabetes, blood pressure, and kidney health in Indigenous communities to see if it can help identify people at risk for kidney disease and improve their care.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.